Glaxo Group Limited

Radleys Discovery Technologies Limited

Mark Ladlow

Mariano Javier Castro

Christopher Kitson

Alpesh Patel

Alan Naylor

Russell Michael Hagan

Keith Thomas Bunce

Barry A Coomber

Andrew Richard Whittington

Adrian Walter Mitchell

Andrew B McElroy

The invention relates to newly identified pentamine based surfactant compounds, to the use of such compounds and their production. The invention also relates to the use of the pentamine based compounds to facilitate the transfer of polynucleotides into cells.

Amide and peptide derivatives of tetraalkylenepentamines as transfection agents

This invention relates to newly identified spermidine based surfactant compounds, to the use of such compounds and to their production. The invention also relates to the use of the spermidine based compounds to facilitate the transfer of polynucleotides into cells.

Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents

This invention relates to newly identified ester-linked gemini surfactant compounds, to the use of such compounds and to their production. The invention also relates to the use of the ester-linked gemini surfactant compounds to facilitate the transfer of polynucleotides into cells.

Compounds

This invention relates to newly identified ester-linked Gemini surfactant compounds of formula (I), where Y is either H or (Aa)x where (Aa) is a basic amino acid and x is 1 to 6, to the use of such compounds and to their production. The invention also relates to the use of the ester-linked Gemini surfactant compounds to facilitate the transfer of polynucleotide into cells.

Ester-linked gemini surfactant compounds for use in gene therapy

A reaction station for performing parallel synthesis with magnetic stirring. The device is capable of accommodating a plurality of reaction vessels being specifically adapted so that when placed in a magnetic field, such as that generated by a laboratory magnetic stirrer, any reaction vessel accommodated by the device is in an effective position for stirring with respect to the magnetic field.

Parallel reaction station with magnetic stirring

The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel tachykinin antagonists of formula (I), processes for their preparation, pharmaceutical compositions containing them and their medical use. ##STR1## wherein R represents the ring A ##STR2## or 2-pyridinyl or 2-pyridinyl-N-oxide; R.sup.1 is selected from halogen atoms and C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl, and S(O).sub.n C.sub.1-4 alkyl groups;

Growing community of inventors

Cambridge, United Kingdom

Mark Ladlow